BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 28552053)

  • 1. Microneedle Patches as Drug and Vaccine Delivery Platform.
    Li J; Zeng M; Shan H; Tong C
    Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneedles-Based Transdermal Drug Delivery Systems: A Review.
    Hao Y; Li W; Zhou X; Yang F; Qian Z
    J Biomed Nanotechnol; 2017 Dec; 13(12):1581-1597. PubMed ID: 29490749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedles for vaccine delivery: challenges and future perspectives.
    Shin CI; Jeong SD; Rejinold NS; Kim YC
    Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
    Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
    Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabies vaccination in dogs using a dissolving microneedle patch.
    Arya JM; Dewitt K; Scott-Garrard M; Chiang YW; Prausnitz MR
    J Control Release; 2016 Oct; 239():19-26. PubMed ID: 27524283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedle patches for vaccination in developing countries.
    Arya J; Prausnitz MR
    J Control Release; 2016 Oct; 240():135-141. PubMed ID: 26603347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.
    Prausnitz MR
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():177-200. PubMed ID: 28375775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
    Chu LY; Ye L; Dong K; Compans RW; Yang C; Prausnitz MR
    Pharm Res; 2016 Apr; 33(4):868-78. PubMed ID: 26620313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microneedle technologies for (trans)dermal drug and vaccine delivery.
    van der Maaden K; Jiskoot W; Bouwstra J
    J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery.
    Lau S; Fei J; Liu H; Chen W; Liu R
    J Control Release; 2017 Nov; 265():113-119. PubMed ID: 27574991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development.
    Adhikari BB; Goodson JL; Chu SY; Rota PA; Meltzer MI
    Drugs R D; 2016 Dec; 16(4):327-338. PubMed ID: 27696306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term stability of influenza vaccine in a dissolving microneedle patch.
    Mistilis MJ; Joyce JC; Esser ES; Skountzou I; Compans RW; Bommarius AS; Prausnitz MR
    Drug Deliv Transl Res; 2017 Apr; 7(2):195-205. PubMed ID: 26926241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
    Cahill EM; O'Cearbhaill ED
    Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microneedle Systems for Vaccine Delivery: the story so far.
    Hossain MK; Ahmed T; Bhusal P; Subedi RK; Salahshoori I; Soltani M; Hassanzadeganroudsari M
    Expert Rev Vaccines; 2020 Dec; 19(12):1153-1166. PubMed ID: 33427523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.
    Hong X; Wei L; Wu F; Wu Z; Chen L; Liu Z; Yuan W
    Drug Des Devel Ther; 2013; 7():945-52. PubMed ID: 24039404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
    An M; Liu H
    Small; 2017 Jul; 13(26):. PubMed ID: 28544329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedle technology for potential SARS-CoV-2 vaccine delivery.
    McNamee M; Wong S; Guy O; Sharma S
    Expert Opin Drug Deliv; 2023 Jun; 20(6):799-814. PubMed ID: 37128730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles vaccination using a microneedle patch.
    Edens C; Collins ML; Ayers J; Rota PA; Prausnitz MR
    Vaccine; 2013 Jul; 31(34):3403-9. PubMed ID: 23044406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.